Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With <i>IDH</i>-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
Psychophysiology|November 13, 2022
Dynamic autonomic nervous system states arise during emotions and manifest in basal physiologyLorenzo Pasquini, Fatemeh Noohi, Christina R Veziris, et al.
Affective Science|November 4, 2025
Testing Models of Resilience in University Students: A Multi-Site StudyEllen Jopling, Taylyn Jameson, Stevi G Ibonie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignanciesKaren W L Yee, Anne Hagey, Srdan Verstovsek, et al.
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|December 14, 2020
Enhanced visceromotor emotional reactivity in dyslexia and its relation to salience network connectivityVirginia E Sturm, Ashlin R K Roy, Samir Datta, et al.
Oncotarget|May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Oncotarget|September 26, 2015
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Cancer|November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignanciesMinny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Molecular Cancer Therapeutics|May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics SystemFilip Janku, Helen J Huang, Bart Claes, et al.
Pageof 10